Aspire Biopharma Holdings Inc (NASDAQ:ASBP) has a beta value of 0.74 and has seen 1.37 million shares traded in the last trading session. The company, currently valued at $16.34M, closed the last trade at $0.33 per share which meant it lost -$0.02 on the day or -4.71% during that session. The ASBP stock price is -4687.88% off its 52-week high price of $15.80 and 33.33% above the 52-week low of $0.22. If we look at the company’s 10-day average daily trading volume, we find that it stood at 9.11 million shares traded. The 3-month trading volume is 15.07 million shares.
Aspire Biopharma Holdings Inc (NASDAQ:ASBP) trade information
Sporting -4.71% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ASBP stock price touched $0.33 or saw a rise of 44.95%. Year-to-date, Aspire Biopharma Holdings Inc shares have moved -96.97%, while the 5-day performance has seen it change 13.01%. Over the past 30 days, the shares of Aspire Biopharma Holdings Inc (NASDAQ:ASBP) have changed -12.42%. Short interest in the company has seen 0.67 million shares shorted with days to cover at 0.02.
Aspire Biopharma Holdings Inc (ASBP) estimates and forecasts
The company’s shares have lost -97.16% over the past 6 months.
ASBP Dividends
Aspire Biopharma Holdings Inc is expected to release its next earnings report in August this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Aspire Biopharma Holdings Inc (NASDAQ:ASBP)’s Major holders
Insiders own 33.08% of the company shares, while shares held by institutions stand at 2.90% with a share float percentage of 4.34%. Investors are also buoyed by the number of investors in a company, with Aspire Biopharma Holdings Inc having a total of 16.0 institutions that hold shares in the company.
